Uptake by J774 macrophages of very-low-density lipoproteins isolated from apoE-deficient mice is mediated by a distinct receptor and stimulated by lipoprotein lipase
article
Apolipoprotein (apo) E-deficient mice display marked accumulation in the plasma of VLDL deficient in both apoE and apoBl00 but containing apoB48, apoA-1, apoCs, and apoA-IV. Since apoE-deficient mice develop severe atherosclerotic lesions with lipid-laden macrophages, we reasoned that the uptake of lipoproteins by intimal macrophages can take place in the absence of both apoE and apoB100. To get more insight into the mechanism of foam cell formation in apoE-deficient mice, we measured the interaction of VLDL from apoE-deficient mice (apoE(null) VLDL) with the murine macrophage cell line J774. Scatchard analysis revealed that apoE(null) VLDL is bound to J774 cells with a K(d) value comparable to that of control VLDL (8.1 versus 4.7 μg/mL) and with a B(max) value about half that of control VLDL (40 versus 70 ng/mg cell protein, respectively). ApoE(null) VLDL is also taken up and degraded by J774 macrophages via a high-affinity process less efficiently than control mouse VLDL (6-fold and 50-fold less efficiently, respectively). In line with this observation, incubation of J774 cells with 50 μg/mL apoE(null) VLDL for 24 hours resulted in an increase in intracellular cholesteryl ester ICE) content, although 5-fold less pronounced than after incubation with 50 μg/mL control mouse VLDL. Under the conditions applied, simultaneous addition of 5 μg/mL lipoprotein lipase (LPL) stimulated the cellular uptake and degradation of apoE(null) VLDL about 10-fold and resulted in a 5-fold stimulation of the intracellular CE accumulation, from 9±2 to 46±5 μg CE per milligram cell protein. In contrast to control mouse VLDL, apoE(null) VLDL could not compete with 125I-labeled LDL for binding to the LDL receptor of J774 cells. Furthermore, neither LDL nor acetylated LDL could compete with 125I-labeled apoE(null) VLDL for binding to these cells, whereas control mouse VLDL, VLDL from a hypertriglyceridemic patient, and apoE(null) VLDL itself were efficient competitors. Thus, VLDL from apoE-deficient mice is taken up by J774 macrophages through recognition by a distinct receptor, which could be the triglyceride-rich lipoprotein receptor. We conclude that in apoE-deficient mice, foam cell formation occurs via a receptor-mediated uptake of apoE(null) VLDL, which can be stimulated by the presence of LPL. Chemicals/CAS: Apolipoproteins E; Lipoprotein Lipase, EC 3.1.1.34; Lipoproteins, VLDL; Receptors, Lipoprotein
Topics
apoE-deficient micefoam cellslipoprotein lipasemacrophagesreceptor-mediated uptakeapolipoprotein a1apolipoprotein a4apolipoprotein b100apolipoprotein ccholesterol esterlipoprotein receptorreceptor proteintriacylglycerolvery low density lipoproteinanimal cellanimal experimentanimal modelatherosclerotic plaquecell linecontrolled studyfoam cellhyperlipoproteinemia type 3intimalipoprotein metabolismmacrophagemousenonhumanAnimalsApolipoproteins EBiological TransportCell LineLipoprotein LipaseLipoproteins, VLDLMacrophagesMiceRadioligand AssayReceptors, Lipoprotein
TNO Identifier
233883
ISSN
10795642
Source
Arteriosclerosis, Thrombosis, and Vascular Biology, 17(3), pp. 498-504.
Pages
498-504
Files
To receive the publication files, please send an e-mail request to TNO Repository.